Page 8 - Lysinek Specific Methyltransferase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kura Oncology (NASDAQ:KURA) Shares Gap Up to $11 04

Kura Oncology (NASDAQ:KURA) Shares Gap Up to $11 04
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesThomas malleyCantor fitzgeraldExchange traded conceptsDenali advisorsNisa investment advisorsAllspring global investments holdingsKura oncology incKura oncologyGet free reportDirector thomas malleyInvestment advisorsGlobal investments holdingsLysinek specific methyltransferaseKura oncology daily

Analysts Set Kura Oncology, Inc (NASDAQ:KURA) PT at $30 00

Analysts Set Kura Oncology, Inc (NASDAQ:KURA) PT at $30 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesThomas malleyStifel nicolausKura oncology company profileDenali advisorsNisa investment advisorsKura oncology incAllspring global investments holdingsKura oncologyGet free reportMarketbeat ratingsDirector thomas malleyInvestment advisorsGlobal investments holdingsGyon technologies capital managementGet free

Kura Oncology, Inc (NASDAQ:KURA) Given Average Recommendation of Moderate Buy by Analysts

Kura Oncology, Inc (NASDAQ:KURA) Given Average Recommendation of Moderate Buy by Analysts
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausThomas malleyRaymond james associatesDimensional fund advisorsCantor fitzgeraldKura oncology company profileMetlife investment managementBridgefront capitalVanguard group incKura oncology incKura oncologyGet free reportDirector thomas malleyLife investment managementFund advisors

Kura Oncology (NASDAQ:KURA) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock. A number of other equities analysts also recently issued reports on KURA. BTIG Research initiated coverage on […]

United statesStifel nicolausThomas malleyKura oncology incAllspring global investments holdingsCantor fitzgeraldNisa investment advisorsSecurities exchange commissionDenali advisorsKura oncologyFree reportModerate buyOncology stock downGet free reportDirector thomas malleyExchange commission

Cantor Fitzgerald Reaffirms Overweight Rating for Kura Oncology (NASDAQ:KURA)

Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $30.00 target price on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 172.73% from the […]

United statesStifel nicolausThomas malleySuvretta capital managementKura oncology company profileVanguard group incSecurities exchange commissionCantor fitzgeraldKura oncology incBlackrock incKura oncologyGet free reportOncology stock downDirector thomas malleyExchange commissionCapital management